Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00988845 · ClinicalTrials.gov registry record · Phase 2
Indole-3-Carbinol Effects on Estrogen Metabolism
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00988845 is a Phase 2 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 38 participants.
The verdict
NCT00988845, a Phase 2 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will test a dietary supplement, indole-3-carbinol, for improving the estrogen profile in women across a range of body mass index.
Interventions
- DIETARY_SUPPLEMENT Indole-3-carbinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00988845
The ClinicalTrials.gov registry entry for NCT00988845 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indole-3-carbinol is the first listed.
NCT00988845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00988845 about?
NCT00988845 is a clinical study titled "Indole-3-Carbinol Effects on Estrogen Metabolism". This study will test a dietary supplement, indole-3-carbinol, for improving the estrogen profile in women across a range of body mass index.
What is the current status of trial NCT00988845?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2009-09. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00988845?
The interventions under investigation include: Indole-3-carbinol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00988845?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.